Novartis to Buy Out Alcon from Nestle

Novartis AG (NVS) offered to buy the rest of Alcon Inc. (ACL), the world's largest eye-care company, from Nestle SA (NSRGY) and minority shareholders for about $39.3 billion, as Chief Executive Officer Daniel Vasella expands into eye surgery.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.